Robert W. Baird Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $575.00

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its target price reduced by stock analysts at Robert W. Baird from $600.00 to $575.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the medical equipment provider's stock. Robert W. Baird's price target points to a potential upside of 20.11% from the stock's current price.

ISRG has been the topic of a number of other reports. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Truist Financial reduced their target price on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. Finally, Leerink Partners upped their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $610.62.

Intuitive Surgical Stock Performance

ISRG stock opened at $478.74 on Wednesday. The business has a 50-day simple moving average of $517.55 and a two-hundred day simple moving average of $532.24. The company has a market capitalization of $170.52 billion, a P/E ratio of 74.69, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical has a 52-week low of $367.39 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company posted $1.50 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last three months. Company insiders own 0.70% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Global Financial Private Client LLC grew its holdings in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Finally, BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.